Cargando…
The Values of Receptor Activator Nuclear Kappa-B Ligand Expression in Stage III Giant Cell Tumor of the Bone
BACKGROUND: Giant cell tumor (GCT) of bone is a benign locally aggressive primary bone tumor which is risky for local recurrences and pulmonary metastasis. Till date, there are still many uncertainties in predicting the aggressiveness of GCT. We aim to investigate whether receptor activator nuclear...
Autores principales: | Ghani, Sabrina Abdul, Wan Ismail, Wan Faisham, Md. Salleh, Md. Salzihan, Yahaya, Sahran, Syahrul Fitri, Zawawi Muhamad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791229/ https://www.ncbi.nlm.nih.gov/pubmed/29416167 http://dx.doi.org/10.4103/ortho.IJOrtho_153_17 |
Ejemplares similares
-
Evaluation of the Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Expression in Osteosarcoma and Its Association with the Clinicopathological Data
por: Chua, Hui Heng, et al.
Publicado: (2021) -
Ki-67 immuno-histochemistry index in stage III giant cell tumor of the bone
por: Ismail, Faisham W, et al.
Publicado: (2010) -
Retrospective Analysis of Giant Cell Tumor Lower End Radius Treated with En bloc Excision and Translocation of Ulna
por: Vyas, Amit, et al.
Publicado: (2018) -
Giant cell tumor of the talus: A case report
por: Galvan, Dana, et al.
Publicado: (2020) -
Effect of Intravenous Zoledronic Acid on Histopathology and Recurrence after Extended Curettage in Giant Cell Tumors of Bone: A Comparative Prospective Study
por: Kundu, Zile Singh, et al.
Publicado: (2018)